Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
Eknath Kole, Krishna Jadhav, Nitin Shirsath, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 81, pp. 104261-104261
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations – A review
Mohit Kumar, Ayah Rebhi Hilles, Samah Hamed Almurisi, et al.
JCIS Open (2023) Vol. 12, pp. 100095-100095
Open Access | Times Cited: 48
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 36
A critical review on developments in drying technologies for enhanced stability and bioavailability of pharmaceuticals
Krishna Jadhav, Eknath Kole, Raghuraj Singh, et al.
Drying Technology (2024) Vol. 42, Iss. 9, pp. 1415-1441
Closed Access | Times Cited: 12
Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues
Panoraia I. Siafaka, Ece Özcan Bülbül, Αndroulla N. Miliotou, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105381-105381
Closed Access | Times Cited: 9
Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery
Thiago Medeiros Zacaron, Mariana Leite Simões e Silva, Mirsiane Pascoal Costa, et al.
Polymers (2023) Vol. 15, Iss. 18, pp. 3849-3849
Open Access | Times Cited: 22
Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation
Krishna Jadhav, Agrim Jhilta, Raghuraj Singh, et al.
Biomaterials Advances (2023) Vol. 154, pp. 213594-213594
Closed Access | Times Cited: 19
A critical analysis of the CFD-DEM simulation of pharmaceutical aerosols deposition in upper intra-thoracic airways: Considerations on air flow
G.H. Spasov, Riccardo Rossi, Andrea Vanossi, et al.
Computers in Biology and Medicine (2024) Vol. 170, pp. 107948-107948
Open Access | Times Cited: 7
Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression
Agrim Jhilta, Krishna Jadhav, Raghuraj Singh, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 8, pp. 2567-2583
Closed Access | Times Cited: 6
Effective cerebral tuberculosis treatment via nose-to-brain transport of anti-TB drugs using mucoadhesive nano-aggregates
Krishna Jadhav, Agrim Jhilta, Raghuraj Singh, et al.
Nanoscale (2024) Vol. 16, Iss. 35, pp. 16485-16499
Closed Access | Times Cited: 4
Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies
Eupa Ray, Krishna Jadhav, Monika Kadian, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 38, pp. 9740-9759
Closed Access | Times Cited: 4
Trans-nasal brain delivery of anti-TB drugs by methyl-β-cyclodextrin microparticles show efficient mycobacterial clearance from central nervous system
Krishna Jadhav, Agrim Jhilta, Raghuraj Singh, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 671-686
Closed Access | Times Cited: 4
Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases
Limei Cui, Yujuan Yang, Hao Yan, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Improved Solubility Predictions in scCO2 Using Thermodynamics-Informed Machine Learning Models
Dmitriy M. Makarov, Nikolai N. Kalikin, Yury A. Budkov, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Advances in spray drying technology for anti-tubercular formulation development: A comprehensive review
Eknath Kole, Krishna Jadhav, Yogesh A. Sonar, et al.
Drying Technology (2025), pp. 1-37
Closed Access
Rifampicin-loaded phthalated cashew gum nano-embedded microparticles intended for pulmonary administration
Joandra Maísa da Silva Leite, Antônia Carla de Jesus Oliveira, Douglas Dourado, et al.
International Journal of Biological Macromolecules (2025) Vol. 303, pp. 140693-140693
Closed Access
Applications of nanotherapeutics and nanotheranostics in the management of various bacterial infections
Kaisar Raza, Nishtha Chaurawal, Ajay Pandey, et al.
Elsevier eBooks (2025), pp. 307-338
Closed Access
Nanotherapeutics in pulmonary infections
Sanchit Arora, Archna Panghal, Jayant Kumar, et al.
Elsevier eBooks (2025), pp. 81-114
Closed Access
Treatment of lung diseases via nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments?
Meekha George, Rabah Boukherroub, Amitav Sanyal, et al.
Materials Today Bio (2025) Vol. 31, pp. 101616-101616
Open Access
Evaluation of lipid-based formulation for pulmonary delivery
Mazen Al-Mohaya, Yavuz Selim Çelik, Burcu Demiralp
Elsevier eBooks (2025), pp. 337-352
Closed Access
Exploring the state-of-art of lipid nanomedicines for obstructive pulmonary diseases
Himanshu Sharma, Monika Kaushik, Sumel Ashique, et al.
Elsevier eBooks (2025), pp. 191-231
Closed Access
Effect of environment of the respiratory tract on nanomedicine drug delivery
Muhammad Imran, Arshi Chaudhary, Masood Ali, et al.
Elsevier eBooks (2025), pp. 49-68
Closed Access
Inhalable Pyrazinamide Loaded Lipid Polymer Hybrid Nanoparticles: In vitro and In vivo Lung Deposition Studies
Komal Parmar, Urvi Mav
Hacettepe University Journal of the Faculty of Pharmacy (2025) Vol. 45, Iss. 1, pp. 57-70
Closed Access
Evolution and Advancements in Inhalation Therapy: A Comprehensive Review from Nebulizers to Dry Powder Inhalers
Mayur R Waje, Annasaheb S Gaikwad, Krishnaraj S. Rathod, et al.
Research Journal of Pharmacy and Technology (2025), pp. 436-444
Closed Access
Nanoparticle-Based Dry Powder Inhaler Containing Ciprofloxacin for Enhanced Targeted Antibacterial Therapy
Petra Party, Márk László Klement, Bianca Maria Gaudio, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 486-486
Open Access
Targeted Drug Delivery System for Pulmonary Fibrosis: Design and Development of Biomaterials
Jinsha Liu, Zifeng Pan, Aatif Khan, et al.
BIO Integration (2025) Vol. 6, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top